Michael Shirazi
Internal Medicine · Elmhurst, NYNPI 1447215140
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Novo Nordisk at 26.4% of the total. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 216 payments — averaging $25.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Viiv Healthcare Company$1K
- Gilead$683
- Lilly USA, LLC$637
- Sirtex Medical Inc$378
- AbbVie$212
- plus $1K from 19 others
What the payments were for
- Food & beverage$5,578100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 61 | $1,473 |
| Viiv Healthcare Company | 41 | $1,051 |
| Gilead | 31 | $683 |
| Lilly USA, LLC | 28 | $637 |
| Sirtex Medical Inc | 8 | $378 |
| AbbVie | 9 | $212 |
| Penumbra, Inc. | 5 | $174 |
| Varian Medical Systems, Inc. | 1 | $140 |
| Pfizer | 5 | $108 |
| Amgen | 4 | $101 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $100 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Bausch Health US, LLC | 3 | $64 |
| Corcept Therapeutics | 2 | $47 |
| Kaleo, Inc. | 2 | $43 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Astellas Pharma US Inc | 1 | $30 |
| Dermira, Inc. | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 1 | $28 |
| Corium, LLC | 1 | $27 |
| Exact Sciences | 1 | $26 |
| Bavarian Nordic A/s | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Trisalus Life Sciences, Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIR-Spheres Microspheres$150
- APRETUDE$125
- Descovy$125
- Wegovy$124
- TOUJEO$100
How this compares
$5,578 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 11 | $1,077 |
| Rosuvastatin Calcium | 25 | $563 |
| Atorvastatin Calcium | 45 | $341 |
| Zolpidem Tartrate ErZolpidem Tartrate | 12 | $307 |
| Metoprolol Succinate | 16 | $254 |
| Amlodipine Besylate | 34 | $137 |
| Finasteride | 13 | $85 |
| Lisinopril | 11 | $43 |
| Simvastatin | 12 | $40 |
| Metformin Hcl | 11 | $37 |
| Losartan Potassium | 12 | $30 |
| Metformin Hcl ErMetformin Hcl | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Elmhurst
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.